Published in Br Med J on September 12, 1970
Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest (1967) 5.03
"What is inherited--what is added" hypothesis for the pathogenesis of diabetes mellitus. Diabetes (1967) 3.08
Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus. Diabetes (1960) 1.63
Ultrastructural changes in islets of the rat produced by tolbutamide. Diabetes (1962) 1.55
Islet-cell metabolism during insulin release. Effects of glucose, citrate, octanoate, tolbutamide, glucagon and theophylline. Biochem J (1969) 1.29
Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, 3, IV, and V hyperlipoproteinemia. Diabetes (1969) 1.22
CLINICAL STUDIES OF TOLAZAMIDE AND TOLBUTAMIDE: COMPARATIVE EFFECTIVENESS OF CONTROL OF DIABETES MELLITUS. Can Med Assoc J (1963) 1.01
Biochemical studies of "prediabetes". Diabetes (1966) 1.01
CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE). Curr Ther Res Clin Exp (1964) 0.96
Clinical experience with the oral antidiabetic compound, tolazamide. Can Med Assoc J (1967) 0.82
LONG-TERM OBSERVATIONS ON ORAL HYPOGLYCEMIC AGENTS IN DIABETES; THE EFFECT OF CARBUTAMIDE AND TOLBUTAMIDE. Diabetes (1965) 0.82
An adrenergic receptor mechanism for the control of cyclic 3'5' adenosine monophosphate synthesis in tissues. Biochem Biophys Res Commun (1967) 2.55
Stimulation of insulin secretion by theophylline. Nature (1967) 1.89
Pathogenesis of diabetic microangiopathy: the roles of endothelial cell and basement membrane abnormalities. Diabet Med (1992) 1.44
Sharing the care of diabetic patients between hospital and general practitioners: does it work? Diabet Med (1993) 1.40
Diabetes to the year 2000 and beyond. National Action Plan. Med J Aust (1993) 1.38
A new assay for adenosine 3',5'-cyclic monophosphate in tissue. Biochemistry (1967) 1.35
Development of the diabetes knowledge (DKN) scales: forms DKNA, DKNB, and DKNC. Diabetes Care (1984) 1.30
Testicular function in potential sperm donors: normal ranges and the effects of smoking and varicocele. Int J Androl (1984) 1.29
Somatogenic receptors of rat liver: regulation by insulin. Endocrinology (1980) 1.23
Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin Chem (1982) 1.22
Adrenal function in patients with active tuberculosis. Thorax (1989) 1.21
Abnormalities of insulin secretion in dystrophia myotonica. Brain (1970) 1.18
Changes in hepatic glutathione metabolism in diabetes. Diabetes (1991) 1.16
Secondary amenorrhea with inappropriate lactation. Observations on etiology, estrogen-gonadotropin interrelationships, the behavior of human growth hormone, and the response to treatment. Am J Obstet Gynecol (1970) 1.13
New forms of insulin and their use in the treatment of diabetes. Diabetes (1977) 1.13
Limited joint mobility in the diabetic foot: relationship to neuropathic ulceration. Diabet Med (1988) 1.12
Antigenicity of "monocomponent" pork insulin in diabetic subjects. Diabetes (1975) 1.11
Cloning of TC-1 (C8orf4), a novel gene found to be overexpressed in thyroid cancer. Genomics (2000) 1.10
High affinity insulin binding and insulin receptor-effector coupling: modulation by Ca2+. Cell Calcium (1990) 1.08
Hypoglycemic action of fenfluramine in diabetes mellitus. Diabetes (1973) 1.07
Young's syndrome. Obstructive azoospermia and chronic sinopulmonary infections. N Engl J Med (1984) 1.07
Testicular damage after radioactive iodine (I-131) therapy for thyroid cancer. Clin Endocrinol (Oxf) (1983) 1.04
Perifusion and culture of human fetal pancreas. Diabetes (1980) 1.03
A method for estimation of Krebs cycle and related intermediates in animal tissues by gas chromatography. Anal Biochem (1968) 1.02
Anti-smoking programme for diabetic patients: the agony and the ecstasy. Diabet Med (1989) 1.02
Why does ethnicity affect prevalence of gestational diabetes? The underwater volcano theory. Diabet Med (1996) 1.02
The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes (1982) 1.00
A high prevalence of obesity in a diabetic population: results of a survey of food patterns in 252 patients in a 2 year period. Diabetes Res Clin Pract (1985) 0.99
The measurement of glycosylated hemoglobin in man and animals by aminophenylboronic acid affinity chromatography. Diabetes (1982) 0.99
Diabetes in the Melanesian and Indian peoples of Fiji: a study of risk factors. Diabetes Res Clin Pract (1987) 0.99
The prevention and reversibility of tissue non-enzymatic glycosylation in diabetes. Diabet Med (1986) 0.98
C-peptide secretion and insulin antibodies as determinants of stability in diabetes mellitus. Metabolism (1978) 0.96
Purification of the insulin receptor from human placental membranes. Biochim Biophys Acta (1979) 0.95
Regulation of hepatic growth hormone receptors by insulin. Biochem Biophys Res Commun (1978) 0.94
The thermal stability of collagen in diabetic rats: correlation with severity of diabetes and non-enzymatic glycosylation. Diabetologia (1983) 0.94
Abnormalities of granulation tissue and collagen formation in experimental diabetes, uraemia and malnutrition. Diabet Med (1986) 0.94
Knowledge and attitude change as predictors of metabolic improvement in diabetes education. Soc Sci Med (1990) 0.93
Inhibition of insulin secretion by a phaeochromocytoma. Lancet (1966) 0.93
The activity of the pyruvate dehydrogenase complex in heart and liver from mice during the development of obesity and insulin resistance. Biochem J (1987) 0.93
The effect of body weight and the fatty acid-oxidation inhibitor 2-tetradecylglycidic acid on pyruvate dehydrogenase complex activity in mouse heart. Biochem J (1984) 0.93
Immunoreactive somatomedin-C/insulin-like growth factor I and its binding protein in human milk. J Clin Endocrinol Metab (1984) 0.93
Measurement of emotional adjustment in diabetic patients: validity and reliability of ATT39. Diabetes Care (1986) 0.92
Glycosylation of plasma protein and its relation to glycosylated hemoglobin in diabetes. Diabetes (1980) 0.92
Histologic differentiation of human fetal pancreatic explants transplanted into nude mice. Diabetes (1984) 0.91
Non-enzymatic glycosylation of tissue protein in diabetes in the rat. Diabetologia (1983) 0.91
High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy. Diabetes (1994) 0.91
A single visit diabetes complication assessment service: a complement to diabetes management at the primary care level. Diabet Med (1993) 0.90
Interaction between diabetic patients, their general practitioners and a hospital diabetic clinic. Med J Aust (1991) 0.89
Purification of human placental lactogen. Endocrinology (1966) 0.89
Calcium-dependence of insulin receptor phosphorylation. Biochem J (1983) 0.89
Maturation of the response of human fetal pancreatic explants to glucose. Diabetologia (1985) 0.88
Ascorbic acid metabolism and polyol pathway in diabetes. Diabetes (1989) 0.88
Colonic and oesophageal disturbance in a patient with multiple endocrine neoplasia, type 2b. Aust N Z J Med (1978) 0.87
Ovarian function after renal transplantation: comparison of cyclosporin A with azathioprine and prednisone combination regimens. Br J Obstet Gynaecol (1984) 0.86
Proportion of active dephosphorylated pyruvate dehydrogenase complex in heart and isolated heart mitochondria is decreased in obese hyperinsulinaemic mice. Biochem J (1984) 0.86
The effects of fasting and refeeding on liver glycogen synthase and phosphorylase in obese and lean mice. Horm Metab Res (1992) 0.86
Effects of experimental diabetes, uremia, and malnutrition on wound healing. Diabetes (1987) 0.85
Testicular function after renal transplantation. Clin Endocrinol (Oxf) (1981) 0.85
Interaction of ascorbic acid and glucose on production of collagen and proteoglycan by fibroblasts. Diabetes (1991) 0.85
Rat growth hormone (GH) but not prolactin (PRL) induces both GH and PRL receptors in female rat liver. Endocrinology (1984) 0.84
High glucose reduces generation of plasmin activity by mesangial cells. Microvasc Res (1997) 0.83
Azoospermia after iodine-131 treatment for thyroid carcinoma. Br Med J (1980) 0.83
Streptozotocin is not toxic to the human fetal B cell. Diabetologia (1989) 0.82
Radioimmunoassay of human plasma apolipoproteins part 1. assay of apolipoprotein-B. Atherosclerosis (1975) 0.82
The lipolytic action of human placental lactogen on isolated fat cells. Biochim Biophys Acta (1967) 0.82
Equilibrium binding studies of insulin antibodies in diabetic subjects. Clin Chem (1976) 0.82
Cell-associated proteoglycans of retinal pericytes and endothelial cells: modulation by glucose and ascorbic acid. Microvasc Res (1994) 0.81
Changes in nucleotides following the addition of adenosine diphosphate to platelet suspensions. Australas Ann Med (1965) 0.81
Deficiency of ascorbic acid in experimental diabetes. Relationship with collagen and polyol pathway abnormalities. Diabetes (1988) 0.80
The role of calcium in insulin release from the human fetal pancreas. Cell Calcium (1990) 0.80
Diabetes education: whose priorities are met? Diabet Med (1992) 0.80
Gradient gel electrophoresis of human plasma lipoproteins. Clin Chem (1973) 0.79
Testicular function and glycemic control in diabetic men. A controlled study. Andrologia (1985) 0.79
Prevalence and distribution of ret/ptc 1, 2, and 3 in papillary thyroid carcinoma in New Caledonia and Australia. J Clin Endocrinol Metab (2000) 0.79
Clinical trial of an aldose reductase inhibitor in diabetic neuropathy. Diabetes (1981) 0.79
Effect of glucose on matrix metalloproteinase activity in mesangial cells. Nephron (1998) 0.79
Abnormalities of ascorbic acid metabolism and diabetic control: differences between diabetic patients and diabetic rats. Diabetes Res Clin Pract (1990) 0.79
Experience with human fetal pancreatic allografts over a three-year period. Transplant Proc (1987) 0.79
Effect of prostaglandin F2 alpha on the secretion of human prolactin. Prostaglandins (1974) 0.79
Decrease in serum receptor-reactive somatomedin in diabetes. Horm Metab Res (1979) 0.79
Heterozygote detection in congenital adrenal hyperplasia. Clin Chem (1983) 0.78
Myocarditis associated with toxoplasmosis. Australas Ann Med (1966) 0.78
Comparison of different models of diabetes care on compliance with self-monitoring of blood glucose by memory glucometer. Diabetes Care (1988) 0.78
Stimulation of protein synthesis in isolated hepatocytes by somatomedin. Metabolism (1978) 0.78
Dexamethasone suppression of adrenocortical function. Clin Chem (1982) 0.78
The activity of the pyruvate dehydrogenase complex in heart muscle in the previously obese mouse model. Biosci Rep (1986) 0.78
The role of the mesangial cell and its matrix in the pathogenesis of diabetic nephropathy. Cell Mol Biol (Noisy-le-grand) (1999) 0.78
Glycosylated hemoglobin as an index of the prevalence and severity of diabetes in biethnic Fiji. Diabetes Res Clin Pract (1987) 0.78
Peripheral neuropathy in acromegaly. Brain (1974) 0.78
Induction of somatogenic receptors in livers of hypersomatotropic rats. Endocrinology (1982) 0.78
The effect of salicylates on nonenzymatic glycosylation and thermal stability of collagen in diabetic rats. Diabetes (1984) 0.77
Insulin inhibition of calcium binding by human placental membrane. Biochim Biophys Acta (1981) 0.77
Gestational diabetes--infant malformations and subsequent maternal glucose tolerance. Aust N Z J Obstet Gynaecol (1986) 0.77
Plasma lipoproteins in pregnancy. Horm Res (1976) 0.76
Hypogonadism and massive testicular infiltration due to amyloidosis. J Urol (1983) 0.76
Interference in assay of human thyrotropin by endogenous antibodies to bovine thyrotropin. Clin Chem (1982) 0.76
Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminura. Diabet Med (1996) 0.76
Reversal of diabetes in hyperglycaemic nude mice by human fetal pancreas. Transplant Proc (1989) 0.76
Testicular function after renal transplantation: comparison of Cyclosporin A with azathioprine and prednisone combination regimes. Clin Nephrol (1984) 0.76